Paper29670528
Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment.
Harrison EB and 2 others. Front Pharmacol, 2018. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment. Papers, record 29670528. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29670528
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016086 | NCI NIH HHS | United States | P30CA016086 | PubMed and NIH | NIH RePORTER |
| R01 CA215075 | NCI NIH HHS | United States | R01CA215075 | PubMed and NIH | NIH RePORTER |
| T32 CA196589 | NCI NIH HHS | United States | T32CA196589 | PubMed and NIH | NIH RePORTER |
| T32 GM007092 | NIGMS NIH HHS | United States | T32GM007092 | PubMed and NIH | NIH RePORTER |
References136
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28855514 | Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers. | Nat Commun | 2017 | https://conductscience.org/library/papers/28855514 | PubMed |
| 2 | 16111635 | Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. | Immunity | 2005 | https://conductscience.org/library/papers/16111635 | PubMed |
| 3 | 20138662 | Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. | Biomaterials | 2010 | https://conductscience.org/library/papers/20138662 | PubMed |
| 4 | 26451105 | Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy. | Int J Nanomedicine | 2015 | https://conductscience.org/library/papers/26451105 | PubMed |
| 5 | 22307839 | Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer. | Cancer Res | 2012 | https://conductscience.org/library/papers/22307839 | PubMed |
| 6 | 10429244 | A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. | Nat Biotechnol | 1999 | https://conductscience.org/library/papers/10429244 | PubMed |
| 7 | 24036551 | microRNA-mediated regulation of the tumor microenvironment. | Cell Cycle | 2013 | https://conductscience.org/library/papers/24036551 | PubMed |
| 8 | 21160526 | RNA interference in the clinic: challenges and future directions. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21160526 | PubMed |
| 9 | 19135886 | MicroRNA control in the immune system: basic principles. | Cell | 2009 | https://conductscience.org/library/papers/19135886 | PubMed |
| 10 | 10837079 | DNA vaccines: immunology, application, and optimization*. | Annu Rev Immunol | 2000 | https://conductscience.org/library/papers/10837079 | PubMed |
| 11 | 23423979 | Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. | Cancer Res | 2013 | https://conductscience.org/library/papers/23423979 | PubMed |
| 12 | 16520032 | Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. | Eur J Cancer | 2006 | https://conductscience.org/library/papers/16520032 | PubMed |
| 13 | 15207531 | PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. | Eur J Pharm Biopharm | 2004 | https://conductscience.org/library/papers/15207531 | PubMed |
| 14 | 18950807 | Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. | J Urol | 2008 | https://conductscience.org/library/papers/18950807 | PubMed |
| 15 | 21629292 | Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/21629292 | PubMed |
| 16 | 28220118 | Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles. | Front Immunol | 2017 | https://conductscience.org/library/papers/28220118 | PubMed |
| 17 | 28700955 | Liver specific gene immunotherapies resolve immune suppressive ectopic lymphoid structures of liver metastases and prolong survival. | Biomaterials | 2017 | https://conductscience.org/library/papers/28700955 | PubMed |
| 18 | 17988871 | Cell integrins: commonly used receptors for diverse viral pathogens. | Trends Microbiol | 2007 | https://conductscience.org/library/papers/17988871 | PubMed |
| 19 | 11350889 | Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11350889 | PubMed |
| 20 | 15778705 | Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. | Nat Biotechnol | 2005 | https://conductscience.org/library/papers/15778705 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40585000 | Riding the wave of innovation: nanotechnology in nucleic acid-based cancer therapy. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40585000 | PubMed |
| 38204162 | The landscape of nanoparticle-based siRNA delivery and therapeutic development. | Mol Ther | 2024 | https://conductscience.org/library/papers/38204162 | PubMed |
| 37376190 | Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37376190 | PubMed |
| 36591314 | EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation. | Front Immunol | 2022 | https://conductscience.org/library/papers/36591314 | PubMed |
| 36358807 | Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358807 | PubMed |
| 35486115 | Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors. | Immunol Res | 2022 | https://conductscience.org/library/papers/35486115 | PubMed |
| 35335310 | Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy. | Molecules | 2022 | https://conductscience.org/library/papers/35335310 | PubMed |
| 34298666 | Albumin Nanostructures for Nucleic Acid Delivery in Cancer: Current Trend, Emerging Issues, and Possible Solutions. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298666 | PubMed |
| 32440473 | Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer. | Adv Sci (Weinh) | 2020 | https://conductscience.org/library/papers/32440473 | PubMed |
| 31728272 | Targeted Delivery of siRNA Lipoplexes to Cancer Cells Using Macrophage Transient Horizontal Gene Transfer. | Adv Sci (Weinh) | 2019 | https://conductscience.org/library/papers/31728272 | PubMed |
| 31406253 | The miR-200-Quaking axis functions in tumour angiogenesis. | Oncogene | 2019 | https://conductscience.org/library/papers/31406253 | PubMed |
| 30918328 | Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis. | Oncogene | 2019 | https://conductscience.org/library/papers/30918328 | PubMed |
| 30541917 | Liposomal Nanostructures for Drug Delivery in Gastrointestinal Cancers. | J Pharmacol Exp Ther | 2019 | https://conductscience.org/library/papers/30541917 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29670528
GET https://conductscience.org/api/papers/v1/29670528/references?page=2